Study Period: January 1, 2022 – February 28, 2023
Role: Principal Investigator (PI)
Location: National Institute of Cardiovascular Diseases (NICVD), Dhaka, Bangladesh
Description: I served as Principal Investigator for the TOFCAPI Trial, a prospective observational study conducted at NICVD, Dhaka, investigating the therapeutic impact of modified-release trimetazidine in patients with ischaemic cardiomyopathy and reduced ejection fraction (LVEF < 35%).